<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-21237" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Epilepsia Partialis Continua</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Khan</surname>
            <given-names>Zalan</given-names>
          </name>
          <aff>University of Missouri Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Arya</surname>
            <given-names>Kapil</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bollu</surname>
            <given-names>Pradeep C.</given-names>
          </name>
          <aff>University of Missouri</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Zalan Khan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Kapil Arya declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Pradeep Bollu declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>28</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-21237.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Epilepsia partialis continua (EPC) is a rare condition involving recurrent and sometimes intractable focal onset seizures associated with retained awareness. EPC seizures can occur over hours, days, or even years. The disease can manifest in a variety of ways, a few of which include myoclonic epilepsy, localized myoclonus, Jacksonian epilepsy, or sensorimotor clonic seizures. The localized nature of the seizures along with preserved consciousness and postictal confusion and weakness (Todd paralysis) are characteristic of the disorder but not pathognomonic. Treatment is centered on a combination of anti-epileptics coupled with identification and resolution of the underlying cause. This activity reviews when epilepsia partialis continua should be considered, how to properly evaluate for it, and the role of the interprofessional team in caring for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Outline the causes of epilepsia partialis continua.</p></list-item><list-item><p>Review features that should prompt consideration of epilepsia partialis continua on differential diagnosis.</p></list-item><list-item><p>Explain the etiology-dependent management of epilepsia partialis continua.</p></list-item><list-item><p>Summarize the role of collaboration amongst interprofessional team members to improve care coordination and minimize oversight, leading to earlier diagnosis and treatment and better outcomes for patients with epilepsia partialis continua.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21237&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21237">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-21237.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Epilepsia partialis continua (EPC) is a rare brain disorder where a patient experiences recurrent and, sometimes, unrelenting focal onset seizures with retained awareness occurring over hours, days, or even years. The pathophysiology of the disease is understood to be complicated. The disease can manifest in a variety of forms such as myoclonic epilepsy, localized myoclonus, Jacksonian epilepsy, and sensorimotor clonic seizures to name a few. Both cortical and subcortical mechanisms have been identified as an etiology. The localized nature of the seizures along with preserved consciousness and postictal confusion and weakness (Todd paralysis) are understood to be characteristic of the disorder but may not be&#x000a0;considered&#x000a0;pathognomonic due to recorded exceptions. Treatment is centered on a combination of anti-epileptic medications coupled with the identification and resolution of the underlying cause.<xref ref-type="bibr" rid="article-21237.r1">[1]</xref>&#x000a0;</p>
        <p>The disorder was first described in 1894 by the legendary Russian neurologist Aleksei Kozhevnikov (1836-1902). The eponym Kozhevnikov epilepsy was coined as a tribute to his work. He postulated that the seizures in EPC were due to a form of focal cortical encephalitis and the subsequent inflammation of cerebral motor fibers. Several years later, in 1958, Rasmussen syndrome (chronic focal encephalitis) was formally&#x000a0;described in which patients with the syndrome presented with seizures like that of EPC. Over the years, several neuroscientists have offered different explanations and interpretations for the possible pathophysiological mechanisms.<xref ref-type="bibr" rid="article-21237.r2">[2]</xref></p>
      </sec>
      <sec id="article-21237.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The list of neurological diseases related to epilepsia partialis continua (EPC) is essentially endless, reflecting the diverse nature of the disease. The causes of EPC are very similar to that of any other form of epilepsy as the basic reason for seizures is abnormal electrical activity in the brain brought on by a myriad of pathologies including architectural damage, cortical dysplasia (such as Tuberous Sclerosis, Sturge-Weber syndrome, and linear sebaceous nevus syndrome), drugs, metabolic abnormalities (hyponatremia, hypoglycemia, hyperglycemia, hyperuricemia, uremia), neoplastic process (oligodendroglioma, meningioma, high grade glioma), autoimmune processes (autoimmune encephalitides), or infections. Rasmussen encephalitis or chronic focal encephalitis (CFE), a rare neurological disease seen in children, has shown a strong association with EPC according to the current literature.<xref ref-type="bibr" rid="article-21237.r3">[3]</xref></p>
      </sec>
      <sec id="article-21237.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The incidence of&#x000a0;epilepsia&#x000a0;partialis&#x000a0;continua (EPC) is reported to be slightly higher in males compared to females.<xref ref-type="bibr" rid="article-21237.r4">[4]</xref>&#x000a0;EPC is a rare disease and has mostly been&#x000a0;reported in the form of case reports across the years. Some regional studies, such as the one conducted in the United Kingdom (UK) by Cockerell et al., have reported a prevalence of one per one million over a one-year study period.<xref ref-type="bibr" rid="article-21237.r5">[5]</xref>&#x000a0;Similarly, Sinha et al. reported a mean age of 30.2 +/-23.4 in their cohort at a tertiary health care hospital in India for more than 14 years.<xref ref-type="bibr" rid="article-21237.r6">[6]</xref></p>
      </sec>
      <sec id="article-21237.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Kozhevnikov and researchers later examining his work believed the seizures in epilepsia partialis continua (EPC) were cortical in origin&#x000a0;and related to some form of localized encephalitis. Hyperexcitability of anterior horn cells was, at the time, believed to be the underlying cause of diseases such as familial progressive myoclonic epilepsy of Unverricht which, like EPC, presented with myoclonic jerks.<xref ref-type="bibr" rid="article-21237.r7">[7]</xref>&#x000a0;This thought process was later proven inconclusive after considering subsequent literature. Early studies using electroencephalogram (EEG) and somatosensory evoked potentials (SSEPs) showed that the waveforms associated with EPC had a positive wave followed by negative shifts with a train of superimposed spikes. Hyperexcitability of the motor cortex and consequent exaggerated responses were also understood to play a part in the disease process.<xref ref-type="bibr" rid="article-21237.r8">[8]</xref>&#x000a0;Inherent lateral inhibition displayed in the neocortex is understood to keep specific pathway-associated responses precise. This phenomenon may be the reason for the localized nature of seizures seen in EPC compared to seizures arising from allocortex of the limbic pathways which is, by design, meant to spread excitation. Some evidence has also shown Jacksonian spread and secondary generalization of seizures, highlighting the complex pathophysiology of the disease.<xref ref-type="bibr" rid="article-21237.r9">[9]</xref>&#x000a0;Studies involving 2-deoxy-D-glucose positron emission tomography (PET) scans, magnetoencephalogram (MEG), and single-photon emission computed tomography (SPECT) have shown that the cortical focus involved EPC is hypermetabolic, hyperactive, and has increased blood flow.<xref ref-type="bibr" rid="article-21237.r10">[10]</xref></p>
        <p>Studies on status epilepticus (SE) have shown a failure of gamma-amino-butyric acid (GABA)-ergic inhibition and consequent unimpeded action of N-methyl-D-aspartate (NMDA) at the synaptic level to play a part in sustaining the epileptic activity. Scientists have postulated a similar process involved in EPC and how it is sustained over extended periods of time, but a causal relationship is yet to be&#x000a0;established.<xref ref-type="bibr" rid="article-21237.r11">[11]</xref>Studies have suggested that EPC and its evolution are likely to be related to autoimmune and inflammatory processes involving interleukin 1B and tumor necrosis factor-a. Neuronal cell loss, astrogliosis, and blood-brain barrier damage brought on by these cytokines may contribute to the underlying hyperexcitability of the cortex.<xref ref-type="bibr" rid="article-21237.r12">[12]</xref><xref ref-type="bibr" rid="article-21237.r13">[13]</xref></p>
      </sec>
      <sec id="article-21237.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>A detailed history and neurological examination are warranted due to the extensive myriad of diseases associated with epilepsia partialis continua (EPC).&#x000a0;</p>
        <p>Classically, EPC presents as a focal form of status epilepticus (SE) with a preserved consciousness that is restricted to one part of the body, occurring for one hour or more, recurrent, and associated with postictal confusion and weakness. Due to the complex nature of the disease, patients rarely fall into a single diagnostic criterion and, therefore, require a detailed history and physical examination to delineate the nature and possible&#x000a0;causes of the seizures.<xref ref-type="bibr" rid="article-21237.r14">[14]</xref></p>
        <p>Neurological deficits are closely related to the nature and degree of&#x000a0;severity of the underlying pathology. Motor deficits ranging from quadriparesis to subtle soft palate paresis may be noted. Sensory deficits, similarly, are variable but are less common compared to their motor counterparts. The involvement of the upper extremities is more common. Altered mentation may be seen in patients due to both<bold>&#x000a0;</bold>the associated inter/postictal confusion and the nature/severity of the underlying pathology.<xref ref-type="bibr" rid="article-21237.r15">[15]</xref></p>
      </sec>
      <sec id="article-21237.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>
<bold>Labs</bold>
</p>
        <p>A baseline laboratory workup may be done during the evaluation of patients with epilepsia partialis continua (EPC) involving tests targeted at probable underlying pathology such as metabolic abnormalities, cerebrovascular, or oncologic conditions.</p>
        <p>
<bold>Imaging</bold>
</p>
        <p>MRI findings can help in delineating structural lesions. Focal cortical dysplasia and Rasmussen encephalitis, two common causes of EPC, are more likely to be identified on MRI because of the advancements in imaging quality and technology in recent years. SPECT scanning may be of use in identifying the epileptic focus, given that the facility and the technically&#x000a0;trained staff is available. This imaging modality&#x000a0;is mostly used for research and only sparingly in clinical settings. Standard imaging modalities used during neurological workups, such as computed tomography (CT) and MRI scanning, may show no pathology.<xref ref-type="bibr" rid="article-21237.r16">[16]</xref><xref ref-type="bibr" rid="article-21237.r17">[17]</xref></p>
        <p>
<bold>Electroencephalogram (EEG)</bold>
</p>
        <p>There are no known specific findings on EEG in patients with EPC and can take the form of spikes, sharp waves, and periodic lateralized epileptiform discharges (PLEDs) with slow-wave activity. Sometimes, asymmetrical background slowing is noted. A normal EEG cannot rule out EPC with certainty as the focus of the seizures may be subcortical.<xref ref-type="bibr" rid="article-21237.r14">[14]</xref></p>
        <p>
<bold>Somatosensory evoked potentials</bold>
</p>
        <p>Somatosensory evoked potentials (SSEPs) have been of some help in localizing the focus of the seizures. Studies using SSEPs have shown hyperexcitability of the motor cortex and the subsequent exaggerated responses to peripheral stimuli.<xref ref-type="bibr" rid="article-21237.r5">[5]</xref><xref ref-type="bibr" rid="article-21237.r18">[18]</xref></p>
      </sec>
      <sec id="article-21237.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The underlying pathological condition leading to epilepsia partialis continua (EPC) is the initial focus of the management strategy. The central aspect of any treatment regimen is seizure control using anti-epileptic medication(AED). Some drugs have been seen to be more effective than others, but polytherapy using multiple AEDs is fairly common. Studies have shown that phenytoin and phenobarbital may be more effective than valproate or carbamazepine. Newer AEDs like&#x000a0;levetiracetam,&#x000a0;brivaracetam,&#x000a0;lacosamide, and&#x000a0;zonisamide&#x000a0;may also&#x000a0;be used as&#x000a0;they are well&#x000a0;tolerated.<xref ref-type="bibr" rid="article-21237.r19">[19]</xref><xref ref-type="bibr" rid="article-21237.r20">[20]</xref>&#x000a0;Therapy with felbamate has also shown positive results, particularly in resistant cases.<xref ref-type="bibr" rid="article-21237.r21">[21]</xref>Rasmussen encephalitis has been seen to be responsive to immunosuppressive agents such as rituximab, tacrolimus, intravenous immunoglobulin (IVIG), and plasma exchange.<xref ref-type="bibr" rid="article-21237.r22">[22]</xref><xref ref-type="bibr" rid="article-21237.r23">[23]</xref><xref ref-type="bibr" rid="article-21237.r24">[24]</xref>&#x000a0;Evidence has also shown some&#x000a0;efficacy of ganciclovir and intraventricular interferon alfa in extremely&#x000a0;small cohorts.<xref ref-type="bibr" rid="article-21237.r25">[25]</xref><xref ref-type="bibr" rid="article-21237.r26">[26]</xref></p>
        <p>Surgical interventions such as hemispherectomy may be considered in cases of Rasmussen encephalitis. Furthermore, newer techniques such as repetitive transcranial stimulation and botulinum toxin have reported some&#x000a0;degree of&#x000a0;success in specific cases.<xref ref-type="bibr" rid="article-21237.r27">[27]</xref><xref ref-type="bibr" rid="article-21237.r28">[28]</xref><xref ref-type="bibr" rid="article-21237.r29">[29]</xref></p>
      </sec>
      <sec id="article-21237.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Cerebral venous sinus thrombosis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Cortical dysplasia</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Choreiform</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Encephalitis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Hyperglycemic nonketotic syndrome</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Hyponatremia</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Hemiballismus</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Perinatal central nervous system injury</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Rasmussen's encephalitis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Stroke</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Tic disorder</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21237.s10" sec-type="Staging">
        <title>Staging</title>
        <p>Bancaud et al. proposed a classification for epilepsia partialis continua (EPC) in 1982 based on findings in a cohort of 23 patients.<xref ref-type="bibr" rid="article-21237.r29">[29]</xref></p>
        <p>
<bold>Type 1 (Classic)</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Rolandic fixed lesions</p>
          </list-item>
          <list-item>
            <p>Neurological deficit</p>
          </list-item>
          <list-item>
            <p>Preceding focal motor seizures</p>
          </list-item>
          <list-item>
            <p>The long delay of onset of myoclonic jerks</p>
          </list-item>
          <list-item>
            <p>Localized EEG changes</p>
          </list-item>
          <list-item>
            <p>The nonprogressive course of the disease</p>
          </list-item>
          <list-item>
            <p>Surgical intervention effective</p>
          </list-item>
        </list>
        <p>
<bold>Type 2 (Rasmussen)</bold>
</p>
        <p>Early onset of seizures</p>
        <list list-type="bullet">
          <list-item>
            <p>High frequency of seizures</p>
          </list-item>
          <list-item>
            <p>Abnormal EEG pattern with slow spikes (sharp waves) with variable localization</p>
          </list-item>
          <list-item>
            <p>Progressive course and associated</p>
          </list-item>
          <list-item>
            <p>Neuropsychological symptoms of sleep and behavior</p>
          </list-item>
          <list-item>
            <p>Diffuse cerebral lesions</p>
          </list-item>
          <list-item>
            <p>Short delay of onset of myoclonic jerks</p>
          </list-item>
        </list>
        <p>Furthermore,&#x000a0;Bancaud and his team divided type 2 into three stages.</p>
        <p><bold>Stage 1</bold>. Only focal motor seizures with preserved awareness or loss of awareness</p>
        <p><bold>Stage 2</bold>. Symptoms of EPC along with progressive neuropsychological deterioration</p>
        <p><bold>Stage 3</bold>. The arrest of deterioration and decrease in the frequency of seizure or eventual resolution</p>
      </sec>
      <sec id="article-21237.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Prognosis is mostly dependent on the underlying cause of epilepsia partialis continua (EPC). Children with focal encephalitis, such as those with Rasmussen encephalitis or other degenerative pathologies, tend to&#x000a0;have a poorer prognosis. Furthermore, children experiencing EPC in the late stages of the disease are more likely to have a lethal outcome.<xref ref-type="bibr" rid="article-21237.r15">[15]</xref>Adult-onset EPC involves reversible underlying causes and tends to&#x000a0;have a better prognosis. Aggressive and prompt management is warranted in specific cases due to the propensity of the disease process to worsen or cause permanent structural damage.<xref ref-type="bibr" rid="article-21237.r30">[30]</xref></p>
      </sec>
      <sec id="article-21237.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Epilepsia partialis continua (EPC) is an unusual manifestation of epilepsy composed of a sustained repetition of focal onset seizure fragments in rapid succession. EPC can range from anywhere between one hour to several years. EPC may occur as a single episode, repetitive episodes, or as a chronic progressive or non-progressive disorder. In some cases, EPC may spread or generalize.</p>
        <p>A plethora of etiologies can be local or systemic. Several structural, metabolic and autoimmune disorders may cause EPC, ranging from strokes and hematomas to diseases like Rasmussen encephalitis. The diagnostic workup includes magnetic resonance imaging to clarify the etiology and EEG which typically shows focal epileptiform or slow wave activity but may vary from etiology to etiology. EEG may also be unrevealing and show no abnormal findings.</p>
        <p>The symptoms of&#x000a0;EPC have been interpreted&#x000a0;to be due to cortical hyperexcitability, but the exact pathophysiology is poorly understood due to a high&#x000a0;degree of&#x000a0;variability. In general terms, EPC seems to represent an oscillation of excitation and inhibition in a feedback loop whose mechanisms are still not fully understood. It seems that&#x000a0;EPC only occurs&#x000a0;rarely&#x000a0;in an otherwise healthy brain.</p>
        <p>Treatment options are limited and specific etiologies&#x000a0;have to be taken into consideration, but EPC has shown to be resistant to antiepileptic drugs (AEDs). Hemispherectomy may be a treatment choice in patients with Rasmussen encephalitis. The overall evidence is limited and mostly in the form of case series. A detailed neurological evaluation is warranted, coupled with a consultation with a group of specialists including neurologists, neurosurgeons, neurointensivists, and rehabilitation specialists. It is also important to note that patient attendants must be&#x000a0;educated about this complicated disease and its management options.</p>
      </sec>
      <sec id="article-21237.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21237&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21237">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/neurology/epilepsia-partialis-continua/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=21237">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/21237/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=21237">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-21237.s14">
        <title>References</title>
        <ref id="article-21237.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bancaud</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bonis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Trottier</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Talairach</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dulac</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>[Continuous partial epilepsy: syndrome and disease].</article-title>
            <source>Rev Neurol (Paris)</source>
            <year>1982</year>
            <volume>138</volume>
            <issue>11</issue>
            <fpage>803</fpage>
            <page-range>803-14</page-range>
            <pub-id pub-id-type="pmid">6820177</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21237.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vein</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>van Emde Boas</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Kozhevnikov epilepsy: the disease and its eponym.</article-title>
            <source>Epilepsia</source>
            <year>2011</year>
            <month>Feb</month>
            <volume>52</volume>
            <issue>2</issue>
            <fpage>212</fpage>
            <page-range>212-8</page-range>
            <pub-id pub-id-type="pmid">21204824</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21237.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bien</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Widman</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Urbach</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sassen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kuczaty</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wiestler</surname>
                <given-names>OD</given-names>
              </name>
              <name>
                <surname>Schramm</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Elger</surname>
                <given-names>CE</given-names>
              </name>
            </person-group>
            <article-title>The natural history of Rasmussen's encephalitis.</article-title>
            <source>Brain</source>
            <year>2002</year>
            <month>Aug</month>
            <volume>125</volume>
            <issue>Pt 8</issue>
            <fpage>1751</fpage>
            <page-range>1751-9</page-range>
            <pub-id pub-id-type="pmid">12135966</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21237.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thomas</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Reagan</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Klass</surname>
                <given-names>DW</given-names>
              </name>
            </person-group>
            <article-title>Epilepsia partialis continua. A review of 32 cases.</article-title>
            <source>Arch Neurol</source>
            <year>1977</year>
            <month>May</month>
            <volume>34</volume>
            <issue>5</issue>
            <fpage>266</fpage>
            <page-range>266-75</page-range>
            <pub-id pub-id-type="pmid">404996</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21237.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cockerell</surname>
                <given-names>OC</given-names>
              </name>
              <name>
                <surname>Rothwell</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Marsden</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Shorvon</surname>
                <given-names>SD</given-names>
              </name>
            </person-group>
            <article-title>Clinical and physiological features of epilepsia partialis continua. Cases ascertained in the UK.</article-title>
            <source>Brain</source>
            <year>1996</year>
            <month>Apr</month>
            <volume>119 ( Pt 2)</volume>
            <fpage>393</fpage>
            <page-range>393-407</page-range>
            <pub-id pub-id-type="pmid">8800935</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21237.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sinha</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Satishchandra</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Epilepsia Partialis Continua over last 14 years: experience from a tertiary care center from south India.</article-title>
            <source>Epilepsy Res</source>
            <year>2007</year>
            <month>Apr</month>
            <volume>74</volume>
            <issue>1</issue>
            <fpage>55</fpage>
            <page-range>55-9</page-range>
            <pub-id pub-id-type="pmid">17292588</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21237.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mameni&#x00161;kien&#x00117;</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Epilepsia partialis continua: A review.</article-title>
            <source>Seizure</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>44</volume>
            <fpage>74</fpage>
            <page-range>74-80</page-range>
            <pub-id pub-id-type="pmid">28029552</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21237.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dawson</surname>
                <given-names>GD</given-names>
              </name>
            </person-group>
            <article-title>CEREBRAL RESPONSES TO ELECTRICAL STIMULATION OF PERIPHERAL NERVE IN MAN.</article-title>
            <source>J Neurol Neurosurg Psychiatry</source>
            <year>1947</year>
            <month>Aug</month>
            <volume>10</volume>
            <issue>3</issue>
            <fpage>134</fpage>
            <page-range>134-40</page-range>
            <pub-id pub-id-type="pmid">21610884</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21237.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chauvel</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Trottier</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vignal</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Bancaud</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Somatomotor seizures of frontal lobe origin.</article-title>
            <source>Adv Neurol</source>
            <year>1992</year>
            <volume>57</volume>
            <fpage>185</fpage>
            <page-range>185-232</page-range>
            <pub-id pub-id-type="pmid">1543053</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21237.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wendling</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Chauvel</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Biraben</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bartolomei</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>From intracerebral EEG signals to brain connectivity: identification of epileptogenic networks in partial epilepsy.</article-title>
            <source>Front Syst Neurosci</source>
            <year>2010</year>
            <volume>4</volume>
            <fpage>154</fpage>
            <pub-id pub-id-type="pmid">21152345</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21237.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mazarati</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Wasterlain</surname>
                <given-names>CG</given-names>
              </name>
            </person-group>
            <article-title>Blockers of NMDA receptor restore paired-pulse inhibition in the rat dentate gyrus lesioned by perforant path stimulation.</article-title>
            <source>Neurosci Lett</source>
            <year>1997</year>
            <month>Oct</month>
            <day>03</day>
            <volume>234</volume>
            <issue>2-3</issue>
            <fpage>135</fpage>
            <page-range>135-8</page-range>
            <pub-id pub-id-type="pmid">9364516</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21237.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nabbout</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Vezzani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dulac</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Chiron</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Acute encephalopathy with inflammation-mediated status epilepticus.</article-title>
            <source>Lancet Neurol</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>99</fpage>
            <page-range>99-108</page-range>
            <pub-id pub-id-type="pmid">21163447</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21237.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Specchio</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Fusco</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Claps</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Vigevano</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Epileptic encephalopathy in children possibly related to immune-mediated pathogenesis.</article-title>
            <source>Brain Dev</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>32</volume>
            <issue>1</issue>
            <fpage>51</fpage>
            <page-range>51-6</page-range>
            <pub-id pub-id-type="pmid">19850427</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21237.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pandian</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Santoshkumar</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Radhakrishnan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sarma</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Joseph</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kesavadas</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Epilepsia partialis continua--a clinical and electroencephalography study.</article-title>
            <source>Seizure</source>
            <year>2002</year>
            <month>Oct</month>
            <volume>11</volume>
            <issue>7</issue>
            <fpage>437</fpage>
            <page-range>437-41</page-range>
            <pub-id pub-id-type="pmid">12237069</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21237.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kravljanac</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Djuric</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jovic</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Djordjevic</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zamurovic</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pekmezovic</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Etiology, clinical features and outcome of epilepsia partialis continua in cohort of 51 children.</article-title>
            <source>Epilepsy Res</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>104</volume>
            <issue>1-2</issue>
            <fpage>112</fpage>
            <page-range>112-7</page-range>
            <pub-id pub-id-type="pmid">23036655</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21237.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yoshida</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tanaka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Masuda</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Okamoto</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hirai</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>[Epilepsia partialis continua with an epileptic focus demonstrated by PET and unique MRI findings: report of a case].</article-title>
            <source>Rinsho Shinkeigaku</source>
            <year>1995</year>
            <month>Sep</month>
            <volume>35</volume>
            <issue>9</issue>
            <fpage>1021</fpage>
            <page-range>1021-4</page-range>
            <pub-id pub-id-type="pmid">8565339</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21237.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burneo</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Hamilton</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vezina</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Parrent</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Utility of Ictal SPECT in the presurgical evaluation of Rasmussen's encephalitis.</article-title>
            <source>Can J Neurol Sci</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>33</volume>
            <issue>1</issue>
            <fpage>107</fpage>
            <page-range>107-10</page-range>
            <pub-id pub-id-type="pmid">16583733</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21237.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schomer</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>Focal status epilepticus and epilepsia partialis continua in adults and children.</article-title>
            <source>Epilepsia</source>
            <year>1993</year>
            <volume>34 Suppl 1</volume>
            <fpage>S29</fpage>
            <page-range>S29-36</page-range>
            <pub-id pub-id-type="pmid">7681771</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21237.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Johannessen</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Tomson</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?</article-title>
            <source>Clin Pharmacokinet</source>
            <year>2006</year>
            <volume>45</volume>
            <issue>11</issue>
            <fpage>1061</fpage>
            <page-range>1061-75</page-range>
            <pub-id pub-id-type="pmid">17048972</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21237.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eggers</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Burghaus</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Fink</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Dohmen</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Epilepsia partialis continua responsive to intravenous levetiracetam.</article-title>
            <source>Seizure</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>18</volume>
            <issue>10</issue>
            <fpage>716</fpage>
            <page-range>716-8</page-range>
            <pub-id pub-id-type="pmid">19836263</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21237.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shi</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Dong</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ni</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Geng</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Felbamate as an add-on therapy for refractory epilepsy.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2014</year>
            <month>Jul</month>
            <day>18</day>
            <issue>7</issue>
            <fpage>CD008295</fpage>
            <pub-id pub-id-type="pmid">25036694</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21237.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bien</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Tiemeier</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sassen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kuczaty</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Urbach</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>von Lehe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Becker</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Bast</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Herkenrath</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Karenfort</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kruse</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kurlemann</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rona</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schubert-Bast</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vieker</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vlaho</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wilken</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Elger</surname>
                <given-names>CE</given-names>
              </name>
            </person-group>
            <article-title>Rasmussen encephalitis: incidence and course under randomized therapy with tacrolimus or intravenous immunoglobulins.</article-title>
            <source>Epilepsia</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>54</volume>
            <issue>3</issue>
            <fpage>543</fpage>
            <page-range>543-50</page-range>
            <pub-id pub-id-type="pmid">23216622</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21237.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bittner</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>OJ</given-names>
              </name>
              <name>
                <surname>G&#x000f6;bel</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bien</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Meuth</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Wiendl</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Rasmussen encephalitis treated with natalizumab.</article-title>
            <source>Neurology</source>
            <year>2013</year>
            <month>Jul</month>
            <day>23</day>
            <volume>81</volume>
            <issue>4</issue>
            <fpage>395</fpage>
            <page-range>395-7</page-range>
            <pub-id pub-id-type="pmid">23794679</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21237.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thilo</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Stingele</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Knudsen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Boor</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bien</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Deuschl</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lang</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>A case of Rasmussen encephalitis treated with rituximab.</article-title>
            <source>Nat Rev Neurol</source>
            <year>2009</year>
            <month>Aug</month>
            <volume>5</volume>
            <issue>8</issue>
            <fpage>458</fpage>
            <page-range>458-62</page-range>
            <pub-id pub-id-type="pmid">19657347</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21237.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McLachlan</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Levin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Blume</surname>
                <given-names>WT</given-names>
              </name>
            </person-group>
            <article-title>Treatment of Rasmussen's syndrome with ganciclovir.</article-title>
            <source>Neurology</source>
            <year>1996</year>
            <month>Oct</month>
            <volume>47</volume>
            <issue>4</issue>
            <fpage>925</fpage>
            <page-range>925-8</page-range>
            <pub-id pub-id-type="pmid">8857720</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21237.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dabbagh</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Gascon</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Crowell</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bamoggadam</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Intraventricular interferon-alpha stops seizures in Rasmussen's encephalitis: a case report.</article-title>
            <source>Epilepsia</source>
            <year>1997</year>
            <month>Sep</month>
            <volume>38</volume>
            <issue>9</issue>
            <fpage>1045</fpage>
            <page-range>1045-9</page-range>
            <pub-id pub-id-type="pmid">9579947</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21237.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Misawa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kuwabara</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shibuya</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mamada</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hattori</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Low-frequency transcranial magnetic stimulation for epilepsia partialis continua due to cortical dysplasia.</article-title>
            <source>J Neurol Sci</source>
            <year>2005</year>
            <month>Jul</month>
            <day>15</day>
            <volume>234</volume>
            <issue>1-2</issue>
            <fpage>37</fpage>
            <page-range>37-9</page-range>
            <pub-id pub-id-type="pmid">15946689</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21237.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Valentin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ughratdar</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Cheserem</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Selway</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Alarcon</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Epilepsia partialis continua responsive to neocortical electrical stimulation.</article-title>
            <source>Epilepsia</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>56</volume>
            <issue>8</issue>
            <fpage>e104</fpage>
            <page-range>e104-9</page-range>
            <pub-id pub-id-type="pmid">26174165</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21237.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Browner</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Azher</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Jankovic</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Botulinum toxin treatment of facial myoclonus in suspected Rasmussen encephalitis.</article-title>
            <source>Mov Disord</source>
            <year>2006</year>
            <month>Sep</month>
            <volume>21</volume>
            <issue>9</issue>
            <fpage>1500</fpage>
            <page-range>1500-2</page-range>
            <pub-id pub-id-type="pmid">16758485</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21237.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>GU</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>DI</given-names>
              </name>
            </person-group>
            <article-title>Alien hand syndrome after epilepsia partialis continua: FDG PET and MRI studies.</article-title>
            <source>Epilepsy Behav</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>23</volume>
            <issue>1</issue>
            <fpage>71</fpage>
            <page-range>71-3</page-range>
            <pub-id pub-id-type="pmid">22100067</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
